Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 19/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2022259 | 0.82 | FFAR1 (0.52) | FFAR1FFAR4MAOBPPARD | |
| SCHEMBL2024484 | 0.82 | MAOB (0.58) | FFAR1MAOBPPARD | |
| SCHEMBL12578548 | 0.79 | FFAR1 (0.66) | FFAR1FFAR4MAOBPPARD | |
| SCHEMBL28485471 | 0.78 | MAOB (0.55) | FFAR1FFAR4MAOB | |
| SCHEMBL2025724 | 0.77 | FFAR1 (0.58) | FFAR1FFAR4MAOB | |
| SCHEMBL12577930 | 0.76 | FFAR1 (0.55) | FFAR1FFAR4MAOB | |
| SCHEMBL2023225 | 0.76 | FFAR1 (0.47) | FFAR1 | |
| SCHEMBL2027506 | 0.76 | FFAR1 (0.59) | FFAR1FFAR4MAOB | |
| SCHEMBL23004608 | 0.75 | MAOB (0.61) | MAOB | |
| SCHEMBL30398602 | 0.75 | MAOB (0.61) | MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968552-B2 | Oxadiazolidinedione compound | ASTELLAS PHARMA INC. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20090186909-A1 | Oxadiazolidinedione Compound | ASTELLAS PHARMA INC. (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-2011788-A1 | OXADIAZOLIDINEDIONE COMPOUND | Astellas Pharma Inc. (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186909-A1 | Oxadiazolidinedione Compound | GPR119, GPR39, GPR65 | FFAR1 64/4885FFAR4 54/4885MAOB 3965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.